Company / Capital Expenditures
Arcellx, Inc. Capital Expenditures History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$2.3M
FY2025
5-year range
$2.3M / $21.4M
FY2021-FY2025
Trend
-82.7%
vs FY2024
Sector context
#94 of 194
Health Care
What the data says
At $2M, Arcellx, Inc.'s capital expenditures ranks #94 of 194 in the Health Care sector. Declined from $21M to $2M over the past 2 years.
Based on SEC 10-K filings.
$2M in FY2025 with a 3-year CAGR of +0.7%.
Declined from $21M to $2M over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- +0.7%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#94 of 194 in Health CareTop 48% of 194This company $2.3M Sector average $117.5M
▼
-98.0% below sector average
Key checks
Key Insights
- 3-year CAGR of +0.7%, indicating consistent growth.
- In FY2025, capital expenditures decreased 82.7% year-over-year.
- Ranks #94 out of 194 companies in the Health Care sector.
- Peak capital expenditures was recorded in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -1.02 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.3M | -82.7% |
| FY2024 | $13.4M | -37.3% |
| FY2023 | $21.4M | +841.1% |
| FY2022 | $2.3M | -60.6% |
| FY2021 | $5.8M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026